KhouryMD
@khourymd.bsky.social
Clinical researcher, rare diseases, eosinophils, healthcare leader, program director, allergy-immunology and AI. Bringer of chocolates, roaster of coffee #MedGrind. Music, art, soccer and food. Value based care mostly for my people. Opining for myself only
I can imagine all the really good things this technology will be used for…
May 21, 2025 at 11:45 AM
I can imagine all the really good things this technology will be used for…
Grants that fund asthma or rare chronic diseases are part of population health. When we study rare diseases there are discoveries of mechanisms that translate into therapies. Also without folks doing the research it only gets slower.
May 21, 2025 at 11:13 AM
Grants that fund asthma or rare chronic diseases are part of population health. When we study rare diseases there are discoveries of mechanisms that translate into therapies. Also without folks doing the research it only gets slower.
Feels like late night QVC?
March 8, 2025 at 2:22 AM
Feels like late night QVC?
Reposted by KhouryMD
Deep thanks to our many collaborators and all research participants. #immunology #science 🧪 @science.org @sarahhross.bsky.social
NIH funding was the lifeblood of this work, as it is for almost all biomedical discoveries and therapies in the U.S. @niaidnews.bsky.social
NIH funding was the lifeblood of this work, as it is for almost all biomedical discoveries and therapies in the U.S. @niaidnews.bsky.social
February 21, 2025 at 1:27 PM
Deep thanks to our many collaborators and all research participants. #immunology #science 🧪 @science.org @sarahhross.bsky.social
NIH funding was the lifeblood of this work, as it is for almost all biomedical discoveries and therapies in the U.S. @niaidnews.bsky.social
NIH funding was the lifeblood of this work, as it is for almost all biomedical discoveries and therapies in the U.S. @niaidnews.bsky.social